Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 106

    1.

    Insulin resistance syndrome in subjects with mutated RING finger protein TRIM37.

    Karlberg N, Jalanko H, Kallijärvi J, Lehesjoki AE, Lipsanen-Nyman M.

    Diabetes. 2005 Dec;54(12):3577-81.PMID: 16306379 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    TRIM37 defective in mulibrey nanism is a novel RING finger ubiquitin E3 ligase.

    Kallijärvi J, Lahtinen U, Hämäläinen R, Lipsanen-Nyman M, Palvimo JJ, Lehesjoki AE.

    Exp Cell Res. 2005 Aug 1;308(1):146-55.PMID: 15885686 [PubMed - indexed for MEDLINE]Related articles

    3.

    Wilms' tumor and novel TRIM37 mutations in an Australian patient with mulibrey nanism.

    Hämäläinen RH, Mowat D, Gabbett MT, O'brien TA, Kallijärvi J, Lehesjoki AE.

    Clin Genet. 2006 Dec;70(6):473-9.PMID: 17100991 [PubMed - indexed for MEDLINE]Related articles

    4.

    The TRIM37 gene encodes a peroxisomal RING-B-box-coiled-coil protein: classification of mulibrey nanism as a new peroxisomal disorder.

    Kallijärvi J, Avela K, Lipsanen-Nyman M, Ulmanen I, Lehesjoki AE.

    Am J Hum Genet. 2002 May;70(5):1215-28. Epub 2002 Apr 5.PMID: 11938494 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.

    Cankurtaran M, Tayfur O, Yavuz BB, Geyik S, Akhan O, Arslan S.

    Acta Gastroenterol Belg. 2007 Jul-Sep;70(3):253-9.PMID: 18074733 [PubMed - indexed for MEDLINE]Related articles

    6.

    Novel mutations in the TRIM37 gene in Mulibrey Nanism.

    Hämäläinen RH, Avela K, Lambert JA, Kallijärvi J, Eyaid W, Gronau J, Ignaszewski AP, McFadden D, Sorge G, Lipsanen-Nyman M, Lehesjoki AE.

    Hum Mutat. 2004 May;23(5):522.PMID: 15108285 [PubMed - indexed for MEDLINE]Related articles

    7.

    A novel splice site mutation in the TRIM37 gene causes mulibrey nanism in a Turkish family with phenotypic heterogeneity.

    Jagiello P, Hammans C, Wieczorek S, Arning L, Stefanski A, Strehl H, Epplen JT, Gencik M.

    Hum Mutat. 2003 Jun;21(6):630-5.PMID: 12754710 [PubMed - indexed for MEDLINE]Related articles

    8.

    Mulibrey nanism: clinical features and diagnostic criteria.

    Karlberg N, Jalanko H, Perheentupa J, Lipsanen-Nyman M.

    J Med Genet. 2004 Feb;41(2):92-8.PMID: 14757854 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Tissue expression of the mulibrey nanism-associated Trim37 protein in embryonic and adult mouse tissues.

    Kallijärvi J, Hämäläinen RH, Karlberg N, Sainio K, Lehesjoki AE.

    Histochem Cell Biol. 2006 Sep;126(3):325-34. Epub 2006 Mar 3.PMID: 16514549 [PubMed - indexed for MEDLINE]Related articles

    10.

    Growth and growth hormone therapy in subjects with mulibrey nanism.

    Karlberg N, Jalanko H, Lipsanen-Nyman M.

    Pediatrics. 2007 Jul;120(1):e102-11. Epub 2007 Jun 4.PMID: 17548484 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    High frequency of tumours in Mulibrey nanism.

    Karlberg N, Karlberg S, Karikoski R, Mikkola S, Lipsanen-Nyman M, Jalanko H.

    J Pathol. 2009 Jun;218(2):163-71.PMID: 19334051 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Characteristics of the populations defined by different criteria of the metabolism syndrome]

    Wei-qiong G, Jie H, Yi-fei Z, Ming-hui G, Min X, Chun-fang S, Wei-qing W, Guang N, Ming-dao C.

    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Dec;28(6):750-5. Chinese. PMID: 17260460 [PubMed - indexed for MEDLINE]Related articles

    14.

    [I/D polymorphism of angiotensin I converting enzyme gene and insulin resistance and some parameters of metabolic syndrome in patients with type 2 diabetes]

    Moleda P, Majkowska L, Safranow K, Adler G, Goracy I, Pilarska K.

    Pol Arch Med Wewn. 2005 Dec;114(6):1172-9. Polish. PMID: 16789486 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome.

    Kowalska I, Straczkowski M, Nikolajuk A, Adamska A, Karczewska-Kupczewska M, Otziomek E, Kinalska I, Gorska M.

    Metabolism. 2008 Nov;57(11):1539-44.PMID: 18940391 [PubMed - indexed for MEDLINE]Related articles

    16.

    Utility of elevated 2-hour postload plasma glucose as an alternative to elevated fasting glucose as a criterion for the metabolic syndrome.

    Kanauchi M, Kanauchi K, Kimura K, Inoue T, Saito Y.

    Metabolism. 2006 Oct;55(10):1323-6.PMID: 16979402 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy]

    Lämmer C, Weimann E.

    Wien Med Wochenschr. 2007 Feb;157(3-4):82-8. German. PMID: 17340066 [PubMed - indexed for MEDLINE]Related articles

    18.

    Insulin resistance and metabolic syndrome in children of parents with diabetes mellitus.

    Altinli S, Elevli M, Ozkul AA, Kara PG, Karsidag K, Dogru M.

    J Pediatr Endocrinol Metab. 2007 Mar;20(3):431-6.PMID: 17451082 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Prevalence of metabolic syndrome and its components in obese children and adolescents]

    Tapia Ceballos L, López Siguero JP, Jurado Ortiz A.

    An Pediatr (Barc). 2007 Oct;67(4):352-61. Spanish. PMID: 17949645 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.

    Huptas S, Geiss HC, Otto C, Parhofer KG.

    Am J Cardiol. 2006 Jul 1;98(1):66-9. Epub 2006 May 4.PMID: 16784923 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data